Mangoceuticals On Aug. 14 Reported Quarter Ended June 30 EPS $(0.09) Up From $(0.14) YoY; Revenue $163,163 Up From $141,237 YoY
Portfolio Pulse from Benzinga Newsdesk
Mangoceuticals reported its financial results for the quarter ended June 30. The company posted an EPS of $(0.09), an improvement from $(0.14) year-over-year. Revenue increased to $163,163 from $141,237 year-over-year.
August 15, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mangoceuticals reported an improved EPS of $(0.09) for Q2, up from $(0.14) YoY, and revenue growth to $163,163 from $141,237 YoY.
The improvement in EPS and revenue growth indicates positive financial performance, which is likely to have a favorable short-term impact on MGRX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100